Literature DB >> 8880918

Purification and crystallization of cyclin-dependent kinase inhibitor p21.

D R Mayrose1, M A Nichols, Y Xiong, H Ke.   

Abstract

p21, a universal inhibitor of mammalian cyclin-dependent kinases (CDK), regulates cell cycle progression by forming various distinct protein complexes with cyclins, CDKs, and the proliferating cell nuclear antigen. We have overexpressed recombinant human p21 in E. coli and purified active p21 to near homogeneity on a large scale. Crystals of recombinant p21 have been grown in the space group P2(1) a = 157.4, b = 152.7, c = 90.6 A, and beta = 92.7 degrees. The diffraction data of the recombinant p21 have been collected to 2.5 and 3.5 A resolution for the native crystal and two heavy atom derivatives of mercury and iridium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880918      PMCID: PMC2143532          DOI: 10.1002/pro.5560050920

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  19 in total

Review 1.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

2.  Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

Authors:  Y Gu; C W Turck; D O Morgan
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

3.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

Authors:  O Halevy; B G Novitch; D B Spicer; S X Skapek; J Rhee; G J Hannon; D Beach; A B Lassar
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

4.  Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.

Authors:  Y Luo; J Hurwitz; J Massagué
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

5.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

6.  Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.

Authors:  H Flores-Rozas; Z Kelman; F B Dean; Z Q Pan; J W Harper; S J Elledge; M O'Donnell; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

7.  Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.

Authors:  H Hirai; M F Roussel; J Y Kato; R A Ashmun; C J Sherr
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

8.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

Authors:  J Chen; P K Jackson; M W Kirschner; A Dutta
Journal:  Nature       Date:  1995-03-23       Impact factor: 49.962

9.  Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.

Authors:  M B Datto; Y Li; J F Panus; D J Howe; Y Xiong; X F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.

Authors:  L Zhu; E Harlow; B D Dynlacht
Journal:  Genes Dev       Date:  1995-07-15       Impact factor: 11.361

View more
  2 in total

1.  Degradation of p21cip1 in cells productively infected with human cytomegalovirus.

Authors:  Z Chen; E Knutson; A Kurosky; T Albrecht
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Vaccinia virus G8R protein: a structural ortholog of proliferating cell nuclear antigen (PCNA).

Authors:  Melissa Da Silva; Chris Upton
Journal:  PLoS One       Date:  2009-05-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.